Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | A |
3. Samples | B |
4. Measurand | A |
5. Pre-Analytical | A |
6. Replicate Analysis | B |
7. Steady State | A |
8. Outlier Analysis | C |
9. Normality | A |
10. Variance Homogeneity | A |
11. ANOVA | A |
12. CI | C |
13. No of Results | C |
14. Concentrations | B |
15. Total Score | C8,12,13 |
Comment | C8,12,13 |
Parameter | Score |
---|---|
Matrix | Serum |
Measurand | Cancer antigen 15-3 (CA 15.3) |
Unit | U / L |
Overall Analytical Principle Method | Immunoassay; RIA |
Number of Subjects | 22 |
Number of Subjects included in BV estimation | 21 |
Ethinicity | Caucasian |
Age Mean / Median | 49.0 |
Age Min | 34.0 |
Age Max | 63.0 |
Age SD | |
Number of Males | 0 |
Number of Females | 22 |
State of Well Being |
Healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 3 |
Study Duration Units | Week |
Sampling Intervals, e.g. X sample(s) per Interval Unit | 5 |
Interval Units | Week |
Sampling Times | Start Time:
07:30
End Time: 09:00 |
Number of Samples | 14 |
Average Number of Samples Used for BV Estimation | 14.0 |
Average Number of Replicates | 1.0 |
Estimates of CVi | 6.2 |
Calculated Confidence Intervals of CVi | Lower: 0.00, Upper: 9.48 |
Estimates of CVg | 62.9 |
Calculated Confidence Intervals of CVg | Lower: 48.35, Upper: 89.95 |
Analytical CV | 11.2 |
Calculated Confidence Intervals of Analytical CV | Lower: 8.92, Upper: 15.06 |
Measurand Mean | |
Measurand Min | |
Measurand Max | |
Measurand SD |